doi: 10.1002/adma.201908185
Am J Alzheimers Dis Other Demen 35:111 Mcclean PL, Parthsarathy V, Faivre E, Hlscher C (2011) The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimers disease
GLP-1 patches are not covered by any form of insurance
Nevertheless, the plateau for selenoprotein P in serum/plasma is achieved at higher levels, i.e., at Se intake of 6070 g/day and plasma Se levels of 90130 g/L (45, 51, 233)
Gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort are dose-dependent and usually improve with slow titration
GLP-1 medications are expensive, and many patients either can't afford or can't tolerate full therapeutic doses